Children's Medical Center Dallas
Dallas, Texas, 75235, United States
NCT Number: NCT05010304
While reported adverse reactions to penicillins are common, most patients with a penicillin allergy label can safely tolerate penicillins, and elective evaluation for penicillin allergy has been recommended. For low-risk patients, direct oral challenge may be an optimal approach as a delabeling strategy. However, there is a vast disparity between the number of patients with a penicillin allergy label and practicing allergists in the United States, and implementing outpatient primary care-based delabeling strategies in low-risk patients may increase access to delabeling assessments. However, a recent survey of pediatricians identified perceived barriers to implementing penicillin allergy evaluations into their routine care. Significant gaps in knowledge exist regarding the feasibility of this approach involving risk stratification evaluation of reported penicillin adverse reactions and direct amoxicillin challenge procedures in low-risk patients in the pediatric primary care setting. With this, the primary aim of this study is to evaluate the number of patients for which risk-stratification and direct amoxicillin challenge are successfully completed in an outpatient pediatric primary care clinic.
Looking for future studies?
Notify Me2 year–18 year
All sexes
Interventional
Phase 4
Dallas, Texas, 75235, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Two-dose amoxicillin challenge
Time frame: Day 1
Time frame: Day 1
Time frame: 10-14 months after amoxicillin challenge
Subjects who have a penicillin allergy label added back to their electronic health record at 10-14 months after amoxicillin challenge.
University of Texas Southwestern Medical Center
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05020327
Penicillin Allergy, Penicillin Intolerance
Cleveland, Ohio, United States
View Trial DetailsNCT00789217
Hypersensitivity, Immune System Diseases
Bangkok, Thailand
View Trial DetailsNCT07604597
Communicable Diseases, Disease Attributes
Manresa, Barcelona, Spain
View Trial DetailsNCT03702270
Penicillin Allergy
Nashville, Tennessee, United States
View Trial Details